Dr. Anna Iwan | Medicine | Research Excellence Award
Featured Publications
BKPyV—Co-Architect of the Fate of a Renal Transplant During a One-Year Observation Period
– International Journal of Molecular Sciences, 2026
Dr. Chong Yin | Associate Researcher | Affiliated Hospital of North Sichuan Medical College | China
Chong Yin holds a comprehensive academic background in biotechnology, animal genetics, and biomedical engineering, progressing from a Bachelor of Science degree in Biotechnology to a Ph.D. in Biomedical Engineering. His educational foundation has equipped him with a strong interdisciplinary understanding of molecular biology, genetic research, and biomedical applications. His work has been widely recognized and cited across multiple scientific platforms, with over fifteen hundred citations by more than thirteen hundred documents. His research output spans over fifty documents, reflecting a significant and sustained contribution to the field. With an h-index of twenty-two, as recorded on Scopus and Google Scholar, his influence in osteogenic and molecular biology research continues to grow.
Chong Yin’s research focuses on the molecular mechanisms governing bone biology, particularly osteoporosis, and the development of nucleic acid-based therapeutics. His work integrates phase separation, gene editing, and hydrogel technologies to explore novel strategies for enhancing bone regeneration and repair. He aims to bridge fundamental cellular biology with translational therapies for skeletal diseases, focusing on innovative approaches for osteogenic differentiation and bone metabolism.
Chong Yin began his professional career as a graduate assistant at the University of Mississippi Medical Center, where he contributed to foundational biomedical research. He then undertook postdoctoral research at Northwestern Polytechnical University, further refining his expertise in cellular and molecular biology. He currently serves as an Associate Researcher and Associate Professor at the Affiliated Hospital of North Sichuan Medical College, where he leads multiple research initiatives in bone biology and regenerative medicine.
Chong Yin has made substantial contributions to understanding osteoblast differentiation, bone formation, and mechanotransduction in skeletal tissues. He has pioneered studies on long noncoding RNAs and microRNAs that regulate bone metabolism and developed biomimetic hydrogels with applications in osteomyelitis treatment. His work has provided valuable insights into the biomechanical mechanisms underlying bone remodeling and the therapeutic potential of RNA-based and hydrogel-mediated interventions.
Chong Yin’s contributions have been recognized with prestigious national and international awards, including grants for young investigators and accolades for innovative research in skeletal disease treatment. His work has garnered recognition for advancing translational approaches in bone biology and regenerative medicine.
He is an active member of multiple scientific societies, including the International Chinese Musculoskeletal Research Society, the Chinese Society of Cell Biology, and the Chinese Anti-cancer Association. He serves as a young editorial member for journals such as iMeta and Burns & Trauma, reflecting his growing influence in scientific publishing and peer review.
Yin, C., Tian, Y., Yu, Y., et al. Long noncoding RNA AK039312 and AK079370 inhibits bone formation via miR-199b-5p. Pharmacol Res.
Yin, C., Tian, Y., Li, D., et al. Long non-coding RNA Lnc-DIF inhibits bone formation by sequestering miR-489-3p. Iscience.
Hu, L., Yin, C., Chen, D., et al. MACF1 promotes osteoblast differentiation by sequestering repressors in cytoplasm. Cell Death Differ.
Tian, Y., Zhao, Y., Yin, C., et al. Polyvinylamine with moderate binding affinity as a highly effective vehicle for RNA delivery. J Control Release.
Yin, C., Zhang, Y., Hu, L., et al. Mechanical unloading reduces microtubule actin crosslinking factor 1 expression to inhibit β-catenin signaling and osteoblast proliferation. J Cell Physiol.
Chong Yin envisions advancing the field of bone biology by translating molecular insights into practical therapies that improve patient outcomes. His research aims to integrate genetic, biochemical, and biomaterial strategies to address skeletal disorders and enhance regenerative medicine approaches, establishing a framework for innovative and clinically relevant treatments.
Postdoctoral Research Fellow, Mass General Brigham, United States
Lova Prasadareddy Kajuluri is a Postdoctoral Research Fellow at the Cardiovascular Research Center, Massachusetts General Hospital (MGH), Charlestown, USA. He is recognized for his significant contributions to cardiovascular research, particularly in understanding vascular calcification and its potential treatments. With a strong background in biotechnology, Kajuluri has advanced in his research career through various prestigious roles in both India and the United States. He holds a Doctorate in Science from the CSIR-Central Drug Research Institute, Lucknow, India, and has received multiple research grants to further his studies in cardiovascular diseases. 🚀
Dr. Luis Javier Martínez Morales earned his Bachelor’s degree in Chemical Biology (QFB), followed by a Master’s in Basic Biomedical Research and a Ph.D. in Microbiology. His educational background equips him with a solid foundation in microbial physiology and biochemistry. 🎓📚
Dr. Martínez Morales has extensive experience in the field of microbiology, focusing on bacterial secondary metabolism and its applications. His work involves studying the production and functionality of key metabolites such as IBA and PHB. His expertise extends to research roles and contributions to various scientific publications. 🧬🔍
Dr. Martínez Morales is dedicated to understanding microbial physiology with a special interest in secondary metabolism. His research includes the production of plant hormones like IBA and the metabolism of PHB by bacteria. He aims to explore the applications of these compounds in biotechnology and agriculture. 🌱🧪
Dr. Martínez Morales has been recognized for his significant contributions to microbiology, particularly in the study of bacterial metabolites. His research has garnered attention and acclaim within the scientific community, highlighting his role in advancing the field of microbial physiology. 🏅🔬
Indole-3-butyric acid (IBA) production in culture medium by wild strain Azospirillum brasilense
Polyhydroxybutyrate Metabolism in Azospirillum brasilense and Its Applications, a Review
Associate Professor, University of Washington, United States
Dr. Sandhya R. Panch, MD, MPH, is an esteemed Associate Professor of Medicine at the University of Washington and the Medical Director of Transfusion at the Fred Hutchinson Cancer Center. With a rich background in hematology and transfusion medicine, Dr. Panch has significantly contributed to both academic and clinical fields. Her extensive experience includes roles at the National Institutes of Health and various prestigious institutions, making her a leading expert in her specialty.
Dr. Panch earned her MBBS from Bangalore Medical College and Research Institute in India. She furthered her education with a Master’s in Public Health (Epidemiology and Biostatistics) from the University of Minnesota. Her postdoctoral training includes a residency in Internal Medicine at Georgetown University Hospital, followed by a Clinical Fellowship in Transfusion Medicine at the National Institutes of Health, where she also completed a Post-doctoral Research Fellowship in Molecular Hematopoiesis under the mentorship of Dr. Cynthia E. Dunbar.
Dr. Panch has held numerous prestigious positions throughout her career. Currently, she serves as an Associate Professor at the University of Washington and Medical Director of Transfusion at Fred Hutchinson Cancer Center. Her previous roles include Assistant Research Physician at the NIH Clinical Center and Medical Director at the Center for Cellular Engineering. She has also served as an Attending Physician at NHLBI, NIH, and INOVA SCHAR Cancer Institute, contributing to both clinical practice and research.
Dr. Panch’s research interests are deeply rooted in hematology and transfusion medicine. She focuses on improving hematopoietic progenitor cell mobilization, understanding the impact of manufacturing-related parameters on CAR T-cell product quality, and exploring the safety and efficacy of various treatments for hematologic conditions. Her work aims to enhance patient outcomes through innovative therapeutic approaches and clinical trials.
Dr. Panch has received numerous awards and grants throughout her career, including the National Blood Foundation Early Career Award and the NIH Clinical Center Research Award for Staff Clinicians Program. She has been recognized for her contributions to hematology and transfusion medicine, reflecting her dedication to advancing medical research and patient care.